Sort by
Refine Your Search
-
Listed
-
Program
-
Employer
-
Field
-
) quantification tools, holding back early immunogenicity risk assessment in the context of protein drug development. A clearer understanding of the rules governing T cell activation would form a paradigm shift in
-
paradigm shift in development of Biologics. A critical challenge preventing this is the current limiting volume of high quality and well-characterized in-vitro T cell immunogenicity data. In this project, we
-
-level programming, developing prototype implementations, and evaluating their research in testbed experiments. An interest in generating real-world impact and collaborating with the industry. Excellent
-
, confocal, super-resolution, and electron: transmission electron microscopy) complementary expertise in image analysis Hands-on experience with epithelial barrier assessment assays (transepithelial
-
innovative services and products which benefit people and create value for society. DTU Health Techs expertise spans from imaging and biosensor techniques, across digital health and biological modelling
-
for society. DTU Health Techs expertise spans from imaging and biosensor techniques, across digital health and biological modelling, to biopharma technologies. The department has a scientific staff of about 210
-
for the globally expanding healthcare sector with its demands for the most advanced technological solutions. DTU Health Tech’s expertise can be described through five overall research areas: Diagnostic Imaging
-
National Mass Spectrometry Platform for Proteomics and Biomolecular Imaging’ (PLATO), which provides a highly international, collaborative, ambitious and innovative research environment in mass spectrometry
-
of epileptic seizures. The first prototype, CEN01, is expected to be implemented in hospitals, giving a more accurate and less time-consuming early detection of seizure. Work description The appointed researcher
-
diseases, particularly in cardiometabolic, brain, and reproductive health. The Centre integrates emerging big data types - such as multi-omics, longitudinal health records, and clinical imaging - to drive